KYOCERA MEDICAL TECHNOLOGIES, INC. – Trademark Portfolio
Entity Type: 03
KYOCERA MEDICAL TECHNOLOGIES, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include SKYWAY, TESERA, BIOCERA, and TESERA TRABECULAR TECHNOLOGY. The owner is based in Redlands, CA.
1200 California Street
Redlands, CA 92374
Showing of trademarks Trademarks
Trademark Classifications
KYOCERA MEDICAL TECHNOLOGIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does KYOCERA MEDICAL TECHNOLOGIES, INC. have?
KYOCERA MEDICAL TECHNOLOGIES, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 3 abandoned.
What trademark classes does KYOCERA MEDICAL TECHNOLOGIES, INC. file in?
KYOCERA MEDICAL TECHNOLOGIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are KYOCERA MEDICAL TECHNOLOGIES, INC.'s most well-known trademarks?
KYOCERA MEDICAL TECHNOLOGIES, INC.'s registered trademark portfolio includes well-known marks such as SKYWAY, TESERA, BIOCERA, and TESERA TRABECULAR TECHNOLOGY. These are among 4 currently registered trademarks in the portfolio.
What is KYOCERA MEDICAL TECHNOLOGIES, INC.'s trademark registration success rate?
KYOCERA MEDICAL TECHNOLOGIES, INC. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 2 applications are pending review.